1 Study Coverage 1.1 Peripheral Intervention Drug-Eluting Devices Product Introduction 1.2 Global Peripheral Intervention Drug-Eluting Devices Outlook 2017 VS 2022 VS 2028 1.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales in US$ Million for the Year 2017-2028 1.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume for the Year 2017-2028 1.3 United States Peripheral Intervention Drug-Eluting Devices Outlook 2017 VS 2022 VS 2028 1.3.1 United States Peripheral Intervention Drug-Eluting Devices Sales in US$ Million for the Year 2017-2028 1.3.2 United States Peripheral Intervention Drug-Eluting Devices Sales in Volume for the Year 2017-2028 1.4 Peripheral Intervention Drug-Eluting Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Peripheral Intervention Drug-Eluting Devices in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Peripheral Intervention Drug-Eluting Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Peripheral Intervention Drug-Eluting Devices Market Dynamics 1.5.1 Peripheral Intervention Drug-Eluting Devices Industry Trends 1.5.2 Peripheral Intervention Drug-Eluting Devices Market Drivers 1.5.3 Peripheral Intervention Drug-Eluting Devices Market Challenges 1.5.4 Peripheral Intervention Drug-Eluting Devices Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Peripheral Intervention Drug-Eluting Devices Market Segment by Type 2.1.1 Drug-Eluting Balloons 2.1.2 Drug-Eluting Stents 2.2 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type 2.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Peripheral Intervention Drug-Eluting Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Peripheral Intervention Drug-Eluting Devices Market Size by Type 2.3.1 United States Peripheral Intervention Drug-Eluting Devices Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Peripheral Intervention Drug-Eluting Devices Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Peripheral Intervention Drug-Eluting Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Peripheral Intervention Drug-Eluting Devices Market Segment by Application 3.1.1 Plain Old Balloon Angioplasty (POBA) 3.1.2 Percutaneous Transluminal Angioplasty (PTA) 3.2 Global Peripheral Intervention Drug-Eluting Devices Market Size by Application 3.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Peripheral Intervention Drug-Eluting Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Peripheral Intervention Drug-Eluting Devices Market Size by Application 3.3.1 United States Peripheral Intervention Drug-Eluting Devices Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Peripheral Intervention Drug-Eluting Devices Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Peripheral Intervention Drug-Eluting Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Peripheral Intervention Drug-Eluting Devices Competitor Landscape by Company 4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Company 4.1.1 Top Global Peripheral Intervention Drug-Eluting Devices Manufacturers Ranked by Revenue (2021) 4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2017-2022) 4.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturer (2017-2022) 4.1.4 Global Peripheral Intervention Drug-Eluting Devices Price by Manufacturer (2017-2022) 4.2 Global Peripheral Intervention Drug-Eluting Devices Concentration Ratio (CR) 4.2.1 Peripheral Intervention Drug-Eluting Devices Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Peripheral Intervention Drug-Eluting Devices in 2021 4.2.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Peripheral Intervention Drug-Eluting Devices Manufacturing Base Distribution, Product Type 4.3.1 Global Peripheral Intervention Drug-Eluting Devices Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Peripheral Intervention Drug-Eluting Devices Product Type 4.3.3 Date of International Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Peripheral Intervention Drug-Eluting Devices Market Size by Company 4.5.1 Top Peripheral Intervention Drug-Eluting Devices Players in United States, Ranked by Revenue (2021) 4.5.2 United States Peripheral Intervention Drug-Eluting Devices Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Peripheral Intervention Drug-Eluting Devices Sales by Players (2020, 2021 & 2022) 5 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region 5.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Peripheral Intervention Drug-Eluting Devices Market Size in Volume by Region (2017-2028) 5.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume by Region: 2017-2022 5.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume Forecast by Region (2023-2028) 5.3 Global Peripheral Intervention Drug-Eluting Devices Market Size in Value by Region (2017-2028) 5.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Value by Region: 2017-2022 5.3.2 Global Peripheral Intervention Drug-Eluting Devices Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2017-2028 6.1.2 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2017-2028 6.3.2 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2017-2028 6.4.2 Latin America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Medtronic plc 7.1.1 Medtronic plc Corporation Information 7.1.2 Medtronic plc Description and Business Overview 7.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Products Offered 7.1.5 Medtronic plc Recent Development 7.2 Boston Scientific Corporation 7.2.1 Boston Scientific Corporation Corporation Information 7.2.2 Boston Scientific Corporation Description and Business Overview 7.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Products Offered 7.2.5 Boston Scientific Corporation Recent Development 7.3 Abbott Laboratories 7.3.1 Abbott Laboratories Corporation Information 7.3.2 Abbott Laboratories Description and Business Overview 7.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Products Offered 7.3.5 Abbott Laboratories Recent Development 7.4 Cardinal Health 7.4.1 Cardinal Health Corporation Information 7.4.2 Cardinal Health Description and Business Overview 7.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Products Offered 7.4.5 Cardinal Health Recent Development 7.5 B. Braun Melsungen AG 7.5.1 B. Braun Melsungen AG Corporation Information 7.5.2 B. Braun Melsungen AG Description and Business Overview 7.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022) 7.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Products Offered 7.5.5 B. Braun Melsungen AG Recent Development 7.6 Biosensors International Group Ltd. 7.6.1 Biosensors International Group Ltd. Corporation Information 7.6.2 Biosensors International Group Ltd. Description and Business Overview 7.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Products Offered 7.6.5 Biosensors International Group Ltd. Recent Development 7.7 C.R. Bard, Inc. 7.7.1 C.R. Bard, Inc. Corporation Information 7.7.2 C.R. Bard, Inc. Description and Business Overview 7.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022) 7.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Products Offered 7.7.5 C.R. Bard, Inc. Recent Development 7.8 Abbott 7.8.1 Abbott Corporation Information 7.8.2 Abbott Description and Business Overview 7.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Products Offered 7.8.5 Abbott Recent Development 7.9 The Lubrizol Corporation 7.9.1 The Lubrizol Corporation Corporation Information 7.9.2 The Lubrizol Corporation Description and Business Overview 7.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022) 7.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Products Offered 7.9.5 The Lubrizol Corporation Recent Development 7.10 Terumo Corporation 7.10.1 Terumo Corporation Corporation Information 7.10.2 Terumo Corporation Description and Business Overview 7.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Products Offered 7.10.5 Terumo Corporation Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Peripheral Intervention Drug-Eluting Devices Industry Chain Analysis 8.2 Peripheral Intervention Drug-Eluting Devices Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Peripheral Intervention Drug-Eluting Devices Distributors 8.3 Peripheral Intervention Drug-Eluting Devices Production Mode & Process 8.4 Peripheral Intervention Drug-Eluting Devices Sales and Marketing 8.4.1 Peripheral Intervention Drug-Eluting Devices Sales Channels 8.4.2 Peripheral Intervention Drug-Eluting Devices Distributors 8.5 Peripheral Intervention Drug-Eluting Devices Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Peripheral Intervention Drug-Eluting Devices CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Peripheral Intervention Drug-Eluting Devices Market Trends Table 3. Peripheral Intervention Drug-Eluting Devices Market Drivers Table 4. Peripheral Intervention Drug-Eluting Devices Market Challenges Table 5. Peripheral Intervention Drug-Eluting Devices Market Restraints Table 6. Global Peripheral Intervention Drug-Eluting Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Peripheral Intervention Drug-Eluting Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Peripheral Intervention Drug-Eluting Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Peripheral Intervention Drug-Eluting Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Peripheral Intervention Drug-Eluting Devices Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturer, 2017-2022 Table 13. Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Manufacturer, 2017-2022 Table 15. Global Peripheral Intervention Drug-Eluting Devices Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global Peripheral Intervention Drug-Eluting Devices Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Peripheral Intervention Drug-Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2021) Table 18. Top Players of Peripheral Intervention Drug-Eluting Devices in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Peripheral Intervention Drug-Eluting Devices Product Type Table 20. Date of International Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Peripheral Intervention Drug-Eluting Devices Players in United States Market, Ranking by Revenue (2021) Table 23. United States Peripheral Intervention Drug-Eluting Devices Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Peripheral Intervention Drug-Eluting Devices Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Peripheral Intervention Drug-Eluting Devices Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Peripheral Intervention Drug-Eluting Devices Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Peripheral Intervention Drug-Eluting Devices Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Peripheral Intervention Drug-Eluting Devices Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Peripheral Intervention Drug-Eluting Devices Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Peripheral Intervention Drug-Eluting Devices Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Peripheral Intervention Drug-Eluting Devices Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Peripheral Intervention Drug-Eluting Devices Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Peripheral Intervention Drug-Eluting Devices Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Peripheral Intervention Drug-Eluting Devices Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Medtronic plc Corporation Information Table 43. Medtronic plc Description and Business Overview Table 44. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Table 46. Medtronic plc Recent Development Table 47. Boston Scientific Corporation Corporation Information Table 48. Boston Scientific Corporation Description and Business Overview Table 49. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. Boston Scientific Corporation Product Table 51. Boston Scientific Corporation Recent Development Table 52. Abbott Laboratories Corporation Information Table 53. Abbott Laboratories Description and Business Overview Table 54. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 55. Abbott Laboratories Product Table 56. Abbott Laboratories Recent Development Table 57. Cardinal Health Corporation Information Table 58. Cardinal Health Description and Business Overview Table 59. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 60. Cardinal Health Product Table 61. Cardinal Health Recent Development Table 62. B. Braun Melsungen AG Corporation Information Table 63. B. Braun Melsungen AG Description and Business Overview Table 64. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. B. Braun Melsungen AG Product Table 66. B. Braun Melsungen AG Recent Development Table 67. Biosensors International Group Ltd. Corporation Information Table 68. Biosensors International Group Ltd. Description and Business Overview Table 69. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 70. Biosensors International Group Ltd. Product Table 71. Biosensors International Group Ltd. Recent Development Table 72. C.R. Bard, Inc. Corporation Information Table 73. C.R. Bard, Inc. Description and Business Overview Table 74. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 75. C.R. Bard, Inc. Product Table 76. C.R. Bard, Inc. Recent Development Table 77. Abbott Corporation Information Table 78. Abbott Description and Business Overview Table 79. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 80. Abbott Product Table 81. Abbott Recent Development Table 82. The Lubrizol Corporation Corporation Information Table 83. The Lubrizol Corporation Description and Business Overview Table 84. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 85. The Lubrizol Corporation Product Table 86. The Lubrizol Corporation Recent Development Table 87. Terumo Corporation Corporation Information Table 88. Terumo Corporation Description and Business Overview Table 89. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 90. Terumo Corporation Product Table 91. Terumo Corporation Recent Development Table 92. Key Raw Materials Lists Table 93. Raw Materials Key Suppliers Lists Table 94. Peripheral Intervention Drug-Eluting Devices Customers List Table 95. Peripheral Intervention Drug-Eluting Devices Distributors List Table 96. Research Programs/Design for This Report Table 97. Key Data Information from Secondary Sources Table 98. Key Data Information from Primary Sources List of Figures Figure 1. Peripheral Intervention Drug-Eluting Devices Product Picture Figure 2. Global Peripheral Intervention Drug-Eluting Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Peripheral Intervention Drug-Eluting Devices Market Size 2017-2028 (US$ Million) Figure 4. Global Peripheral Intervention Drug-Eluting Devices Sales 2017-2028 (K Units) Figure 5. United States Peripheral Intervention Drug-Eluting Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Peripheral Intervention Drug-Eluting Devices Market Size 2017-2028 (US$ Million) Figure 7. United States Peripheral Intervention Drug-Eluting Devices Sales 2017-2028 (K Units) Figure 8. United States Peripheral Intervention Drug-Eluting Devices Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Peripheral Intervention Drug-Eluting Devices Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Peripheral Intervention Drug-Eluting Devices Report Years Considered Figure 11. Product Picture of Drug-Eluting Balloons Figure 12. Product Picture of Drug-Eluting Stents Figure 13. Global Peripheral Intervention Drug-Eluting Devices Market Share by Type in 2022 & 2028 Figure 14. Global Peripheral Intervention Drug-Eluting Devices Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share in Value by Type (2017-2028) Figure 16. Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2028) & (K Units) Figure 17. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Peripheral Intervention Drug-Eluting Devices Price by Type (2017-2028) & (USD/Unit) Figure 19. United States Peripheral Intervention Drug-Eluting Devices Market Share by Type in 2022 & 2028 Figure 20. United States Peripheral Intervention Drug-Eluting Devices Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share in Value by Type (2017-2028) Figure 22. United States Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2028) & (K Units) Figure 23. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Peripheral Intervention Drug-Eluting Devices Price by Type (2017-2028) & (USD/Unit) Figure 25. Product Picture of Plain Old Balloon Angioplasty (POBA) Figure 26. Product Picture of Percutaneous Transluminal Angioplasty (PTA) Figure 27. Global Peripheral Intervention Drug-Eluting Devices Market Share by Application in 2022 & 2028 Figure 28. Global Peripheral Intervention Drug-Eluting Devices Sales in Value by Application (2017-2028) & (US$ Million) Figure 29. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share in Value by Application (2017-2028) Figure 30. Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2028) & (K Units) Figure 31. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share in Volume by Application (2017-2028) Figure 32. Global Peripheral Intervention Drug-Eluting Devices Price by Application (2017-2028) & (USD/Unit) Figure 33. United States Peripheral Intervention Drug-Eluting Devices Market Share by Application in 2022 & 2028 Figure 34. United States Peripheral Intervention Drug-Eluting Devices Sales in Value by Application (2017-2028) & (US$ Million) Figure 35. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share in Value by Application (2017-2028) Figure 36. United States Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2028) & (K Units) Figure 37. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share in Volume by Application (2017-2028) Figure 38. United States Peripheral Intervention Drug-Eluting Devices Price by Application (2017-2028) & (USD/Unit) Figure 39. North America Peripheral Intervention Drug-Eluting Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 40. North America Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 41. U.S. Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 42. Canada Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Europe Peripheral Intervention Drug-Eluting Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 44. Europe Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 45. Germany Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 46. France Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. U.K. Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. Italy Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Russia Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 51. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 52. China Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Japan Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. South Korea Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. India Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Australia Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Taiwan Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Indonesia Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Thailand Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Malaysia Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Philippines Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Latin America Peripheral Intervention Drug-Eluting Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 63. Latin America Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 64. Mexico Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Brazil Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Argentina Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 68. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 69. Turkey Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. U.A.E Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Peripheral Intervention Drug-Eluting Devices Value Chain Figure 73. Peripheral Intervention Drug-Eluting Devices Production Process Figure 74. Channels of Distribution Figure 75. Distributors Profiles Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Medtronic plc Boston Scientific Corporation Abbott Laboratories Cardinal Health B. Braun Melsungen AG Biosensors International Group Ltd. C.R. Bard, Inc. Abbott The Lubrizol Corporation Terumo Corporation